Definitive Contract 75N91021C00017

Award Date 9/13/21

Potential Completion Date 6/21/22

Potential Value $455K

Federal Agency

National Cancer Institute

Awardee

Proteios Technology, Inc.

Ultimate Awardee

Not listed

NAICS Category

541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

PSC Category

AN11 - Health R&D Services; Health Care Services; Basic Research

Federal Contract Vehicle

Set-Aside Type

Total Small Business

Extent Competed

Full and Open Competition after exclusion of sources

Major Defense Program

Not listed

Pricing Type

Firm Fixed Price

Place of Performance

Issaquah, WA, USA

Solicitation Procedures

Negotiated Proposal / Quote

Number Of Offers Received

Legislative Mandate

Employment Eligibility Verification

National Interest Action

Not listed

Research Type

SBIR Program Phase I Action

Primary Consortia Member

Not listed

This contract was awarded by the National Cancer Institute to Proteios Technology, Inc., a self-certified small disadvantaged business. The $455,000 firm-fixed-price contract is for a 1-year Small Business Innovation Research (SBIR) Phase I project focused on developing a new paradigm for autologous and allogeneic cell therapy manufacturing. The contract is part of the NCI's SBIR program, which aims to stimulate technological innovation and increase commercialization of federal research and development. Proteios Technology is a biotech company specializing in sustainable protein purification for the biopharmaceutical and cell therapy sectors. This SBIR Phase I award will support Proteios' research and development activities to advance cell therapy manufacturing processes.

Generated 10/17/24, 9:48 AM

Name	Solicitation Number	Federal Agency	Type	Posted Date (Click to sort descending)
Adjuvanted Virus-Mimicking Nanoparticle HIV Vaccine	PHS2021-1	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Award Notice 4/6	7/2/21, 7:31 AM
Rapid Point of Care Test to Quantify HIV Drugs for Adherence Monitoring	PHS-2021-1	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Award Notice 3/6	7/1/21, 2:36 PM
A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals	PHS-2021-1	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Solicitation 2/6	7/28/20, 1:40 PM
Nannovaccine for Eliciting 10E8-like bnAbs against HIV-1	PHS2021-1	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Award Notice 5/6	7/2/21, 7:48 AM
A Solicitation of the National Institutes of Health (NIH) and The Centers for Disease Control and Prevention (CDC) for Small Business Innovation Research (SBIR) Contract Proprosals	PHS-2021-1	Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases	Pre-Solicitation 1/6	7/9/20, 5:10 PM

Mod #	Reason For Modification	Federal Obligation (Click to sort descending)	Date (Click to sort ascending)
P00002	Exercise an Option	$55.0k	4/4/22
P00001	Other Administrative Action	$0	10/28/21
Not listed	Not listed	$400.0k	9/3/21

Plans
Login

Blog